本文翻译正在准备中。在此之前，我们暂时显示英文原文。
商业 · 2001/2/21 分钟阅读
John J. Ferrante et al; Withdrawal of Approval of 125 Abbreviated New Drug Applications
本地自动翻译 · 来源原始语言
摘要
The Food and Drug Administration (FDA) is withdrawing approval of 125 abbreviated new drug applications (ANDA's). The basis for the withdrawals is that the holders of the applications have repeatedly failed to file required annual reports for these applications.
来源原始语言: Federal Register — Food and Drug Administration打开原始公告 →